New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - human chorionic gonadotrophin highly purified 5 [iu] (material -hormone hcg ex netherlands,belgium); sodium chloride 9mg - injection with diluent - 5 iu - active: human chorionic gonadotrophin highly purified 5 [iu] (material -hormone hcg ex netherlands,belgium) excipient: gelatin mannitol polysorbate 20 water for injection active: sodium chloride 9mg excipient: water for injection

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - human hepatitis b immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) - infusion, solution - 50 iu/ml - human hepatitis b immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) 50 iu/ml

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - human normal immunoglobulin (human plasma protein containing at least 96% immunoglobulin) - infusion, solution - 50 mg/ml - human normal immunoglobulin (human plasma protein containing at least 96% immunoglobulin) 50 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis ex lax inc, united states - tablet - 25 - sennosides

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis ex lax inc, united states - tablet - 15 - sennosides

Israel - English - Ministry of Health

gilead sciences israel ltd - anti-cd19 car t cells - dispersion for infusion - anti-cd19 car t cells - acute lymphoblastic leukaemia tecartus is indicated for the treatment of adult patients with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).mantle cell lymphoma tecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton's tyrosine kinase (btk) inhibitor unless ineligible to btk inhibitor •limitation of use : tecartus is not indicated for the treatment of patients with active central nervous system lymphoma

Israel - English - Ministry of Health

gsk consumer healthcare, israel ltd - calcium carbonate - chewable tablets - calcium carbonate 750 mg - calcium carbonate - calcium carbonate - for relief from heartburn and acidity

Malta - English - Medicines Authority

bayer plc - levonorgestrel - intrauterine delivery system - levonorgestrel 13.5 mg - other gynecologicals

European Union - English - EMA (European Medicines Agency)

dompe farmaceutici s.p.a. - recombinant human nerve growth factor - keratitis - ophthalmologicals - treatment of moderate (persistent epithelial defect) or severe (corneal ulcer) neurotrophic keratitis in adults

United States - English - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - nitroglycerin 0.2 mg in 1 h - transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of transdermal nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute attack. allergic reactions to organic nitrates are extremely rare, but they do occur. nitroglycerin is contraindicated in patients who are allergic to it. allergy to the adhesives used in nitroglycerin patches has also been reported, and it similarly constitutes a contraindication to the use of this product. do not use nitroglycerin transdermal systems in patients who are taking phosphodiesterase inhibitors (such as sildenafil, tadalafil, or vardenafil) for erectile dysfunction or pulmonary arterial hypertension. concomitant use can cause severe drops in blood pressure. do not use nitroglycerin transdermal systems in patients who are taking the soluble guanylate cyclase stimulator riociguat. concomitant use can cause hypotension.